Exagen Inc. financial data

Symbol
XGN on Nasdaq
Industry
Services-Medical Laboratories
Location
1261 Liberty Way, Vista, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
EXAGEN DIAGNOSTICS INC (to 5/18/2017)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 428 % -32.5%
Debt-to-equity 174 % +57.3%
Return On Equity -92.6 % +1.77%
Return On Assets -33.7 % +24.5%
Operating Margin -27.6 % +55.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.6M shares +3.47%
Common Stock, Shares, Outstanding 17.5M shares +3.48%
Entity Public Float 37.3M USD -39.4%
Common Stock, Value, Issued 18K USD +5.88%
Weighted Average Number of Shares Outstanding, Basic 18.3M shares +3.18%
Weighted Average Number of Shares Outstanding, Diluted 18.3M shares +3.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 55.8M USD +8%
Research and Development Expense 4.8M USD -26.1%
Costs and Expenses 71.2M USD -15.1%
Operating Income (Loss) -15.4M USD +52.1%
Net Income (Loss) Attributable to Parent -16.9M USD +47.9%
Earnings Per Share, Basic -0.94 USD/shares +49.7%
Earnings Per Share, Diluted -0.94 USD/shares +49.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 22M USD -22.5%
Accounts Receivable, after Allowance for Credit Loss, Current 9.39M USD -44.9%
Other Assets, Current 2.93M USD +31%
Assets, Current 35.6M USD -27.3%
Property, Plant and Equipment, Net 8.2M USD +71.8%
Operating Lease, Right-of-Use Asset 2.63M USD -36.9%
Goodwill 0 USD -100%
Other Assets, Noncurrent 563K USD -11.8%
Assets 43.6M USD -28.4%
Accounts Payable, Current 1.11M USD -33.3%
Accrued Liabilities, Current 6.18M USD -12.5%
Liabilities, Current 8.78M USD -13.3%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 1.95M USD -46.2%
Other Liabilities, Noncurrent 185K USD -61.8%
Liabilities 30.7M USD -8.04%
Retained Earnings (Accumulated Deficit) -291M USD -6.19%
Stockholders' Equity Attributable to Parent 12.9M USD -53.2%
Liabilities and Equity 43.6M USD -28.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.04M USD +7.27%
Net Cash Provided by (Used in) Financing Activities -100K USD -61.3%
Net Cash Provided by (Used in) Investing Activities -86K USD +78.3%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 17.5M shares +3.48%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.23M USD +9.61%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 22.2M USD -22.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 434K USD -3.34%
Deferred Tax Assets, Valuation Allowance 42.9M USD +11.3%
Deferred Tax Assets, Gross 44M USD +10.2%
Operating Lease, Liability 3.74M USD -32.5%
Payments to Acquire Property, Plant, and Equipment 86K USD -78.3%
Lessee, Operating Lease, Liability, to be Paid 4.28M USD -35.1%
Property, Plant and Equipment, Gross 13.3M USD +53.9%
Operating Lease, Liability, Current 1.07M USD -6.42%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.28M USD -14.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.24M USD -14.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 541K USD -48.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.32M USD -14.2%
Deferred Tax Assets, Operating Loss Carryforwards 32.5M USD +9.03%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 445K USD -71.9%
Operating Lease, Payments 282K USD
Additional Paid in Capital 303M USD +0.76%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.8M USD -21.7%
Deferred Tax Assets, Net of Valuation Allowance 1.1M USD -22%
Share-based Payment Arrangement, Expense 2.09M USD -39.1%
Interest Expense 2.25M USD -9.73%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%